Yelich J V, Geisert R D, Schmitt R A, Morgan G L, McCann J P
Department of Animal Science, Oklahoma State University, Stillwater 74078-0425, USA.
J Anim Sci. 1997 Mar;75(3):745-54. doi: 10.2527/1997.753745x.
Experiments were conducted to test the hypothesis that estrogen treatment will regress a persistent dominant follicle developed during melengestrol acetate (MGA) treatment in the absence of a functional corpus luteum (CL) with normal fertility following development and ovulation of a newly recruited follicle. In Exp. 1, nonlactating beef cows (n = 31) were administered .5 mg.cow-1.d-1 of MGA (d 0) for 14 d with 25 mg of prostaglandin F2 alpha (PGF2 alpha) administered on d 6 and 8 to regress the CL. On d 11 of treatment, approximately half the MGA-treated cows received 5 mg of estradiol valerate (EV) i.m. (MGAEV, n = 14) and the remainder were maintained on MGA (n = 17). Ovaries were checked with ultrasound on d 8, 10, 12, and 14 of MGA treatment and every day until ovulation. A persistent dominant follicle developed in 90% of the MGA-treated cows by d 10 of treatment. Most of the MGA-treated cows ovulated the persistent dominant follicle (n = 13/17), whereas EV treatment regressed the persistent dominant follicle (n = 10/14) with the recruitment of a new follicle that ovulated (n = 8/10). Diameter of the ovulatory follicle was larger (P < .05) for the MGA (19.8 +/- .6 mm) than for the control (15.1 +/- .8 mm) and MGAEV (14.8 +/- .7 mm) cows. In Exp. 2, nonlactating, multiparous beef cows (n = 97) and yearling heifers (n = 38) were equally allotted to either a control, MGA alone, or MGA + estradiol-17 beta (MGAE) group with the same dose of MGA as administered in Exp. 1. The 1st d of MGA feeding was the 1st d of treatment. On d 10 of treatment half the MGA-treated animals were injected i.m. with 5 mg of estradiol-17 beta. In controls, behavioral estrus was detected and animals were artificially inseminated (AI) for 5 d (d 10 to 14 of experiment). All controls not exhibiting estrus by d 15 of experiment were injected with 25 mg of PGF2 alpha. The remaining controls and all MGA cows were observed for behavioral estrus and AI commenced for 7 d following withdrawal of MGA (d 15 to 21 of experiment). More (P < .05) controls (90.3%) than MGA (84.8%) or MGAE (63.6%) cows showed estrus within 7 d after MGA withdrawal. The percentage of animals conceiving to the synchronized estrus did not differ (P > .05) among treatments. The data support our hypothesis that a persistent dominant follicle developed and can be regressed with exogenous estrogen treatment followed by the recruitment and ovulation of a new follicle after MGA withdrawal and fertility of that estrus does not seem to be significantly compromised.
在缺乏功能性黄体(CL)的情况下,雌激素治疗将使在醋酸甲地孕酮(MGA)治疗期间发育的持续优势卵泡消退,随后新募集的卵泡发育并排卵,生育能力正常。在实验1中,对31头非泌乳母牛每天每头给予0.5mg MGA(第0天),持续14天,并在第6天和第8天给予25mg前列腺素F2α(PGF2α)以使黄体消退。在治疗的第11天,大约一半接受MGA治疗的母牛肌肉注射5mg戊酸雌二醇(EV)(MGAEV组,n = 14),其余母牛继续接受MGA治疗(n = 17)。在MGA治疗的第8、10、12和14天以及直至排卵前每天用超声检查卵巢。到治疗第10天时,90%接受MGA治疗的母牛出现了持续优势卵泡。大多数接受MGA治疗的母牛排出了持续优势卵泡(n = 13/17),而EV治疗使持续优势卵泡消退(n = 10/14),同时募集了一个排卵的新卵泡(n = 8/10)。MGA组排卵卵泡的直径(19.8±0.6mm)大于对照组(15.1±0.8mm)和MGAEV组(14.8±0.7mm)的母牛(P < 0.05)。在实验2中(与实验1给予相同剂量的MGA),将97头非泌乳经产母牛和38头一岁小母牛平均分配到对照组、单独MGA组或MGA + 17β-雌二醇(MGAE)组。开始给予MGA的第1天为治疗第1天。在治疗第10天时,一半接受MGA治疗的动物肌肉注射5mg 17β-雌二醇。在对照组中,检测到行为发情,动物进行人工授精(AI)5天(实验第10至14天)。到实验第15天时所有未表现出发情的对照组动物注射25mg PGF2α。其余对照组和所有MGA组母牛观察行为发情,在撤掉MGA后7天开始进行人工授精(实验第15至21天)。撤掉MGA后7天内表现出发情的对照组母牛(90.3%)多于MGA组(84.8%)或MGAE组(63.6%)(P < 0.05)。各处理组中同步发情受孕动物的百分比无差异(P > 0.05)。这些数据支持了我们的假设,即在缺乏功能性黄体的情况下,MGA治疗期间会发育出持续优势卵泡,外源性雌激素治疗可使其消退,随后撤掉MGA后会募集并排卵一个新卵泡,且该发情期的生育能力似乎未受到显著损害。